The largest-ever study on the effects of magnetic resonance imaging on pacemakers and defilibrators has concluded that the imagers are indeed safe for those with these cardiac rhythm management devices.
The largest-ever study on the effects of magnetic resonance imaging on pacemakers and defibrillators has concluded that the imagers are indeed safe for those with these cardiac rhythm management devices.
That’s the conclusion of a new study published in the October edition of Annals of Internal Medicine. The journal also published an editorial and a summary for patients on the findings.
Millions of Americans live with pacemakers and defibrillators, with hundreds of thousands implanted annually. Because of concerns about MRI machines’ intense magnetic fields causing the devices to malfunction, physicians have avoided MRI scans for such patients, though an estimated 75 percent of such patients could benefit from scans, the authors estimated.
A team led by Saman Nazarian, MD, of Johns Hopkins University, conducted 555 MRI scans on 438 patients with pacemakers (237) or defibrillators (201). Of the 555 MRI examinations, 222 (40 percent) were of the brain, 122 (22 percent) were of the spine, 89 (16 percent) were of the heart, 72 (13 percent) were of the abdomen or pelvis, and 50 (9 percent) were of an extremity. The team monitored patients before, during, and after the scans.
Overall, just three patients experienced problems with the devices, and none had a serious problem.
Patients were selected and treated based on previous safety studies. Therefore, only those with pacemakers manufactured after 1998 and defibrillators manufactured after 2000 were enrolled, and the researchers carefully followed programming and monitoring protocol.
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
Diffusion-Weighted MRI and Neoadjuvant Chemotherapy for Rectal Cancer: What New Research Reveals
September 3rd 2024In a comparison of imaging assessments to gauge the effectiveness of neoadjuvant chemotherapy for rectal adenocarcinoma, researchers found the combination of diffusion-weighted imaging and MR tumor regression grading had a 90 percent area under the curve (AUC) and a negative predictive value (NPV) of 93 percent.
FDA Expands Clearance of MRI-Guided AI Platform for Deep Brain Stimulation and Lesioning Techniques
September 3rd 2024Utilizing a new machine learning model, the OptimMRI software may improve radiosurgery applications and lesioning techniques such as MRI-guided focused ultrasound through enhanced targeting of the inferolateral part of the ventral intermediate nucleus (VIM).